Related references
Note: Only part of the references are listed.Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis
Yang Liu et al.
BIOENGINEERED (2022)
circXRCC5 foster gastric cancer growth and metastasis by the HNRNPC/circXRCC5/miR-655-3p/RREB1/UBA2 positive feedback loop
Zuo-Long Liu et al.
CANCER GENE THERAPY (2022)
Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer
Jianyou Gu et al.
MOLECULAR CANCER (2022)
Hyaluronic Acid-Coated Bovine Milk Exosomes for Achieving Tumor-Specific Intracellular Delivery of miRNA-204
Dan Li et al.
CELLS (2022)
M(6)A-mediated up-regulation of LncRNA LIFR-AS1 enhances the progression of pancreatic cancer via miRNA-150-5p/ VEGFA/Akt signaling
Jian-Qing Chen et al.
CELL CYCLE (2021)
Assessment of tissue perfusion of pancreatic cancer as potential imaging biomarker by means of Intravoxel incoherent motion MRI and CT perfusion: correlation with histological microvessel density as ground truth
Philipp Mayer et al.
CANCER IMAGING (2021)
Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990-2019
Longfei Lin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Coordination of Di-Acetylated Histone Ligands by the ATAD2 Bromodomain
Chiara M. Evans et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Early detection of pancreatic cancer using DNA-based molecular approaches
Aatur D. Singhi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Surgery for pancreatic cancer: recent progress and future directions
Zachary J. Brown et al.
HEPATOBILIARY SURGERY AND NUTRITION (2021)
Regulatory Mechanism of MicroRNA Expression in Cancer
Zainab Ali Syeda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Delivery of LNA-antimiR-142-3p by Mesenchymal Stem Cells-Derived Exosomes to Breast Cancer Stem Cells Reduces Tumorigenicity
Zahra Naseri et al.
STEM CELL REVIEWS AND REPORTS (2020)
Angiogenesis in pancreatic cancer: current research status and clinical implications
Shuo Li et al.
ANGIOGENESIS (2019)
miR-655-3p inhibits cell migration and invasion by targeting pituitary tumor-transforming 1 in non-small cell lung cancer
Wei Wang et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2019)
Overexpression of microRNA-186 inhibits angiogenesis in retinoblastoma via the Hedgehog signaling pathway by targeting ATAD2
Shuai Wu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Tumor-secreted dickkopf2 accelerates aerobic glycolysis and promotes angiogenesis in clorectal cancer
Fengliu Deng et al.
THERANOSTICS (2019)
MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
Guangbing Xiong et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Pancreatic Adenocarcinoma Staging in the Era of Preoperative Chemotherapy and Radiation Therapy
Marc Zins et al.
RADIOLOGY (2018)
The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer
Meng-Dan Xu et al.
ONCOGENESIS (2018)
Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft models
Tine Cuppens et al.
GYNECOLOGIC ONCOLOGY (2017)
What treatment in 2017 for inoperable pancreatic cancers?
J. Taieb et al.
ANNALS OF ONCOLOGY (2017)
The Role of Angiogenesis in Cancer Treatment
Mehdi Rajabi et al.
BIOMEDICINES (2017)
Role of microRNAs in regulation of the TNF/TNFR gene superfamily in chronic lymphocytic leukemia
Swati Srivastava et al.
CLINICAL BIOCHEMISTRY (2016)
MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3
Chunyou Wang et al.
ONCOTARGET (2016)
Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer
Le Zheng et al.
ONCOLOGY REPORTS (2015)
ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma
Camilla Krakstad et al.
ONCOTARGET (2015)
Anti-Angiogenic Agents in Pancreatic Cancer: A Review
Murwarid M. Assifi et al.
Anti-Cancer Agents in Medicinal Chemistry (2012)
Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors
Barbara Sennino et al.
CANCER DISCOVERY (2012)
Pancreatic cancer: From molecular signature to target therapy
R. Longo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable?
Andrew H. Ko et al.
INVESTIGATIONAL NEW DRUGS (2008)
Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases
CC Solorzano et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2001)